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Abstract
Background: Massive parallel sequencing has the potential to replace microarrays as the method
for transcriptome profiling. Currently there are two protocols: full-length RNA sequencing (RNA-
SEQ) and 3'-tag digital gene expression (DGE). In this preliminary effort, we evaluated the 3' DGE
approach using two reference RNA samples from the MicroArray Quality Control Consortium
(MAQC).
Results: Using Brain RNA sample from multiple runs, we demonstrated that the transcript profiles
from 3' DGE were highly reproducible between technical and biological replicates from libraries
constructed by the same lab and even by different labs, and between two generations of Illumina's
Genome Analyzers. Approximately 65% of all sequence reads mapped to mitochondrial genes,
ribosomal RNAs, and canonical transcripts. The expression profiles of brain RNA and universal
human reference RNA were compared which demonstrated that DGE was also highly quantitative
with excellent correlation of differential expression with quantitative real-time PCR. Furthermore,
one lane of 3' DGE sequencing, using the current sequencing chemistry and image processing
software, had wider dynamic range for transcriptome profiling and was able to detect lower
expressed genes which are normally below the detection threshold of microarrays.
Conclusion: 3' tag DGE profiling with massive parallel sequencing achieved high sensitivity and
reproducibility for transcriptome profiling. Although it lacks the ability of detecting alternative
splicing events compared to RNA-SEQ, it is much more affordable and clearly out-performed
microarrays (Affymetrix) in detecting lower abundant transcripts.
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Background
The transcriptome can be profiled by high throughput
techniques including SAGE [1], microarray [2,3], and
sequencing of clones from cDNA libraries [4,5]. For more
than a decade, oligo-nucleotide microarrays have been the
method of choice providing high throughput and afford-
able costs. However, microarray technology suffers from
well-known limitations including insufficient sensitivity
for quantifying lower abundant transcripts, narrow
dynamic range and non-specific hybridizations. Addition-
ally, microarrays are limited to only measuring known/
annotated transcripts and often suffer from inaccurate
annotations [6]. Sequencing-based methods such as SAGE
rely upon cloning and sequencing cDNA fragments. This
approach allows quantification of mRNA abundance by
counting the number of times cDNA fragments from a
corresponding transcript are represented in a given sam-
ple, assuming that cDNA fragments sequenced contain
sufficient information to identify a transcript. Sequenc-
ing-based approaches have a number of significant tech-
nical advantages over hybridization-based microarray
methods. The output from sequence-based protocols is
digital, rather than analog, obviating the need for complex
algorithms for data normalization and summarization
while allowing for more precise quantification and greater
ease of comparison between results obtained from differ-
ent samples. Consequently the dynamic range is essen-
tially infinite, if one accumulates enough sequence tags.
Sequence based approaches do not require prior knowl-
edge of the transcriptome and are therefore useful for dis-
covery and annotation of novel transcripts as well as for
analysis of poorly annotated genomes. However, until
recently the application of sequencing technology in tran-
scriptome profiling has been limited by high cost, by the
need to amplify DNA through bacterial cloning, and by
the traditional Sanger approach of sequencing by chain
termination [7].
The next-generation sequencing (NGS) technology [8-10]
eliminates some of these barriers, enabling massive paral-
lel sequencing at a high but reasonable cost for small stud-
ies. The technology essentially reduces the transcriptome
to a series of randomly fragmented segments of a few hun-
dred nucleotides in length. These are amplified by a proc-
ess that retains spatial clustering of the PCR produces, and
individual clusters were sequenced in parallel by one of
several technologies [7]. Current NGS platforms include
the Roche 454 Genome Sequencer, Illumina's Genome
Analyzer, and Applied Biosystems' SOLiD. These plat-
forms can analyze tens to hundreds of millions of DNA
fragments simultaneously, generate giga-bases of
sequence information from a single run, and have revolu-
tionized SAGE and cDNA sequencing technology [11,12].
For example, the 3' tag Digital Gene Expression (DGE)
uses oligo-dT priming for first strand cDNA synthesis, gen-
erates libraries that are enriched in the 3' untranslated
regions of polyadenylated mRNAs, and produces 20-21
base cDNA tags. It's reported that 99.8% of 21-base tags
occur only once in human genome [13], while analyses
based on actual sequence information from approxi-
mately 16,000 known genes suggest that >75% of 21-base
pair tags are expected to occur only once in the human
genome, with the remaining tags matching duplicated
genes or repeat sequences [13]. The work reported in this
manuscript effectively generates 20-base pair tags and the
% of tags mapped to multiple locations on genome would
be slightly higher. The 3' tag DGE profiling using Illumina
Genome Analyzer II generates up to 10-12 million reads
from individual libraries of unique, positionally known
20- or 21- base pair 3' cDNA tags. DGE technology gener-
ates such extensive sequencing depth-of-coverage that sin-
gle copy resolution of gene expression quantification
should be possible. For example, it's generally accepted
that on average there are 350,000 transcripts expressed per
cell (Illumina White Paper: mRNA Expression Analysis).
Therefore a 10 million tag sequencing experiment by the
Illumina GA II would detect 30 tags per transcript
expressed at one copy per cell. This technology makes it
possible, for the first time, to interrogate low abundance
transcripts, which may comprise as much as half of the
non-structural RNA within a cell. The alternative to 3' tag
DGE sequencing is full-length RNA sequencing (RNA-
Seq), which collects both quantitative and qualitative
information about the entire transcriptome. RNA-Seq is a
powerful tool for identifying expressed polymorphisms as
well as differentially expressed splice variants, fusion
genes, transcriptional start sites, and polyadenylylation
sites [14]. However, the number of reads needed to char-
acterize whole transcript sequences, using RNA-Seq,
increases the cost of measuring rare transcripts and may be
more economically quantitated with 3' tag DGE profiling.
Assessment of the 3' DGE method has been limited. One
study used 3' tag DGE approach in mouse hippocampal
expression profiling [15], and another paper compared 3'
tag DGE with SAGE [15]. More research is needed for eval-
uation of the sensitivity, dynamic range, reproducibility,
and measurement accuracy of 3' tag DGE.
Our work focuses on exploring and validating the applica-
bility of 3' tag DGE to the quantification of transcripts. To
this end, we have designed a set of experiments to assess
the use of 3' tag DGE as an alternative to microarrays or to
RNA-Seq. We used two RNA samples described in the
MicroArray Quality Control (MAQC) project [16]:
Human Brain Reference RNA (HBRR) and Universal
Human Reference RNA (UHRR). The samples, from the
exact batches used by the MAQC project, are commer-
cially available to the research community and have been
well-characterized by microarray (repeatedly assayed by 7
microarray platforms) and quantitative real time PCRBMC Genomics 2009, 10:531 http://www.biomedcentral.com/1471-2164/10/531
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(qPCR, 3 quantitative PCR platforms). Therefore, compar-
ing the profiles of these two RNA samples generated by
the 3' tag DGE, by microarray, and by qPCR will provide
an excellent frame of reference for evaluation of the sensi-
tivity, dynamic range, reproducibility, and accuracy of 3'
tag DGE sequencing.
Methods
Library preparation and sequencing
The universal human reference RNA (UHRR) was pur-
chased from Stratagene (catalog no.740000) and the
human brain reference RNA (HBRR) was purchased from
Ambion/Applied Bioscience (catalog no. AM6051). The 3'
tag DGE libraries were constructed from UHRR or HBRR
as described in the Illumina DGE protocol. Total RNA (1-
2 μg) was fractionated using oligo-dT magnetic beads to
yield poly(A+) mRNA. mRNA bound to the beads was
then used as a template for first strand cDNA synthesis
primed by oligo-dT and the second strand cDNA was con-
sequently synthesized using random primers. Next, the
double stranded cDNA covalently attached to oligo-dT
beads was digested with DpnII. The fragments that
remained attached to the beads were ligated to the Illu-
mina GEX DpnII Adapter 1, which includes a MmeI recog-
nition site. Therefore, the library preparation protocol
allows only one tag per RNA molecule. Digestion with
MmeI yielded the adapter tag linked to 20 bp of cDNA
including 4 bp of the DpnII recognition site, which was
ligated to GEX Adapter 2 at the site of MmeI cleavage. The
resulting sequences, tagged on both 5' and 3' ends, were
amplified using PCR and purified on 6% Novex TBE
PAGE gels. A band corresponding to approximately 85
base pairs was cut from the gel, eluted, and concentrated
by precipitation. Integrity of the tagged sequence was con-
firmed using the Agilent 2100 Bioanalyzer. In addition, an
aliquot of each sample was TA cloned into a TOPO vector,
a small number of colonies (typically 6-10) were isolated,
and plasmid DNA was purified from each. Sanger
sequencing was carried out to demonstrate that the librar-
ies were composed of unique clones, each of which con-
tained authentic 3' UTR sequences. Sequencing was
carried out at Mayo Advanced Genomics Technology
Center DNA sequencing lab using the Illumina Genome
Analyzers I and II.
Image processing and read alignment
Illumina Pipeline Software version 1.0 was used for off-
instrument data processing. Images from every sequenc-
ing cycle were converted to signal intensities using Illu-
mina Pipeline's FireCrest v.1.9.5. Next, Bustard v.1.9.5
was run to perform base calling using the intensity values
and calculate quality scores for every base. The 16-base
long reads (excluding the 4-base DpnII recognition site)
were aligned to DpnII  tag tables generated by Stowers
Institute http://research.stowers-institute.org/microarray/
tag_tables/index.html using megaBLAST with word size of
12 and low-complexity region filtering turned off. Only
reads that perfectly matched to tag tables without mis-
matches and gaps were considered. From this set, reads
that could be aligned to the Stowers' repeat tag table were
excluded (the repeat tag table contains any reads aligned
to ≥ 2 locations, unless all locations are from the same
gene). The remaining reads were aligned to the combina-
tion of canonical (exonic and splice junction tags from
protein-coding transcripts), mitochondrial (tags from any
mitochondrion-associated transcripts encoded by both
genomic and mitochondrial DNA), and ribosomal (tags
from rRNA or tRNA) tag tables. Reads mapping on genes
with multiple homologous family members were
excluded from our analysis. When there were multiple
types of tags aligned to different locations of the same
gene, the gene expression levels are represented by the
summation of all.
Microarray data analysis
Five each of Affymetrix Human Genome U133 plus2.0
CEL files for HBRR and UHRR samples from MAQC test
site 1 were downloaded from Gene Expression Omnibus
database (series accession number GSE5350). The CEL
files were pre-processed using GC-RMA[17]. The present,
marginal, or absent calls for individual probe sets were
calculated by Affymetrix MAS 5.0 algorithm. Only the
probe sets with "present" calls in all five samples were
used in the comparison with 3' tag DGE data.
Gene ID mapping between sequencing, Affymetrix 
microarray, and real-time PCR data
Mapping between Affymetrix probe set ID to ENSEMBL
gene was done using the Affymetrix annotation file ver-
sion na27. In instances where multiple probe sets mapped
to a single ENSEMBL identifier, the probe set with the
highest expression was selected. The identification of gene
IDs for qPCR reagents was extracted from the Affymetrix
probe set IDs according to MAQC [18].
Comparison of UHRR and HBRR 3' tag DGE profiles
Eight UHRR and one HBRR libraries were prepared and
compared within sample (HBRR library 1 versus HBRR
library 2, etc.) and across samples (UHRR versus HBRR).
The gene expression was normalized to tag counts per mil-
lion total tags (counts per million tags, CPMT) in each
lane of a flow cell.
Results
Our initial analyses focused on defining the reproducibil-
ity of 3' tag DGE and determining the depth of sequencing
required to achieve a reasonable coverage of the transcrip-
tome. To this end, eight HBRR libraries (L1-L8) and 1
UHRR library (L9) were independently prepared and
sequenced in 6 flow cells for a total of 38 flow cell lanesBMC Genomics 2009, 10:531 http://www.biomedcentral.com/1471-2164/10/531
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(35 lanes for HBRR and 3 lanes for UHRR) of data using
Illumina Genome Analyzer (GA) I and II (Table 1). One
lane from each flow cell was used to run the bacteriophage
ΦX174 DNA control sample. The lane lay-out for individ-
ual sequencing flow-cells (runs) is shown in Table 2.
Run Summaries
The summary of run and alignment statistics for all librar-
ies is provided in Additional File 1. One lane of sequenc-
ing typically generated 3-5 million reads on the GA I and
6-8 million reads on the GA II. On average 54% of the
reads aligned to canonical, 6% aligned to mitochondrial,
and <2% aligned to rRNA tag tables. For simplicities of
comparisons to MAQC results, we merged the canonical,
mitochondrial, and rRNA tag tables into one combined
table in this manuscript. The remaining reads aligned to
repeat (~7%), non-canonical (~3%), non-coding
(~0.02%), and intergenic (~14%) tag tables. Approxi-
mately 15% of reads did not align to the reference tables.
Reproducibility
As shown in Table 1, eight HBRR libraries were sequenced
in order to assess reproducibility between the Genome
Analyzer (GA) II and the older GA I, reproducibility
within- and between- sequencing runs, and reproducibil-
ity between library preparations performed at two Mayo
locations (Minnesota and Florida). First, we looked at the
correlations of the gene expression levels. Figure 1a shows
the pair-wise lane-to-lane Pearson Correlation Coefficient
of the gene expression levels. Except for library 8 (L8) and
to a lesser extent Library 6 (L6), we observed very good
correlations (r > 0.95) of HBRR expression between tech-
nical replicates (same library, same run, different lanes)
and biological replicates (different libraries, same or dif-
ferent runs). The correlations of libraries run on GA I and
GA II were also > 0.95. A complete table containing the
raw gene tag counts (Log2 scale) and full Pearson correla-
tion coefficient matrix, for all sequencing runs, can be
found in Additional File 2.
Second, we looked at the concordance/reproducibility of
gene identification across different lanes and different
libraries. We asked the question: "if a gene was identified
in one lane or one library, how often was it reproducibly
identified in a different lane of the same library, or in a
different library of the same RNA sample"? We defined a
gene as being "identified" when it could be associated to
at least one tag, or 1 CPMT. A total of 18,000 genes with
at least one tag are identified from the combined analysis
of the reads included in the 35 lanes of HBRR sequencing.
Of these genes, 12,825 (71.25%) are repeatedly identified
in all lanes and all libraries, with the other 5,175
(28.75%) detected by less number of lanes and/or librar-
ies (Figure 1b). The small peak in the histogram around
genes identified by 1-5 lanes reflects the groups of
extremely low expressed genes whose expression levels are
around the detection sensitivity threshold of DGE at cur-
rent sequencing depth. As shown in Figure 1c and 1d,
which illustrate the relationship between gene expression
level and number of lanes in which the gene was identi-
fied (Figure 1c), and the histogram of gene expressions
(Figure 1d), all genes not consistently identified in all 35
lanes had expression levels between 1-2 CPMT, or 0.35-
0.7 copies per cell. Since late 2008 and early 2009 when
these libraries were sequenced, the throughput of one lane
Table 1: Summary of 3' tag digital gene expression libraries 
including RNA samples, locations of the lab who prepared the 
libraries, and the library IDs.
RNA Lab Location Library ID
HBRR Florida L1
HBRR Florida L2
HBRR Florida L3
HBRR Minnesota L4
HBRR Minnesota L5
HBRR Minnesota L6
HBRR Minnesota L7
HBRR Minnesota L8
UHRR Florida L9
HBRR: Human Brain Reference RNA; UHRR: Universal Human 
Reference RNA.
Table 2: Flow cell lay-out for individual sequencing runs.
Run # Sequencer Lane Numbers
1 2 34 56 7 8
1 G A  I L 1L 1L 2 L 2 P h i XL 3L 3L 3
2 G A  I L 4L 5L 4 L 5 P h i XL 4L 6L 4
3 GA II L4 L5 L4 PhiX L5 L4 L6 L4
4 GA II L4 L4 L5 PhiX L6 L7 L8 L5
5 GA II L4 L7 L4 PhiX L8 L6 L7 L8
6 GA II L9 --- --- L9 PhiX --- --- L9
Total of 7 runs were performed on Genome Analyzer I (GA I) and 
GA II. There are 8 lanes on each flow cell named as Lanes 1-8, one of 
which was used in each run for a control sample PhiX, the 
bacteriophage DNA.BMC Genomics 2009, 10:531 http://www.biomedcentral.com/1471-2164/10/531
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of sequencing on GA II has increased to 15-20 million
reads, due to new sequencing chemistry and new version
of the Illumina Pipeline Software (v1.4). Therefore, we
expect that the percentage of the genes repeatedly detected
across lanes to be greatly improved. We calculated that
theoretically up to 90% of the current 18,000 genes would
be detected across all 35 lanes with this much higher
sequencing capacity.
Tag to gene relationship
The enzymatic digestion protocol used in the 3' tag DGE
approach is designed to capture the digestion site most
proximal to a transcript polyadenylylation site. If one
assumes complete DpnII digestion during library prepara-
tion and assumes a single polyadenylylation site per gene,
there should be theoretically only one type of tag per tran-
script. However, according to the run summary data in
Reproducibility of 3' tag digital gene expression profiling Figure 1
Reproducibility of 3' tag digital gene expression profiling. 1a - Pearson correlation coefficient matrix of all 8 HBRR 
libraries prepared at two Mayo locations (Minnesota and Florida), sequenced in 35 lanes of 5 different runs on two generations 
of Genome Analyzer (I and II). The rows and columns are all 35 lanes in 5 HBRR sequencing runs, and named using the corre-
sponding library names (L1-L8). The same libraries in each run have been grouped together for visual benefits. The correlation 
coefficient was calculated using Log2 transformed tag counts. The tag counts of zero were coded as missing data. The actual 
numbers of the correlation coefficient are listed in the Additional File 2. The color in each squire of the matrix reflects the 
pair-wise lane-to-lane degree of correlation of gene expression levels; 1b - Concordance of gene detection. Gene expression 
levels are represented by the raw number of reads (dark red) and number of reads per million (yellow). More than 70% of the 
genes were repeatedly detected in all 35 lanes. 1c - The relationship between gene detection and expression levels. Genes that 
were detected in less than 35 lanes were lower expressed at levels of 1-2 CPMT, or 0.35-0.7 copies per cell; 1d - The histo-
gram of gene expression levels.
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Additional File 1, there were on average more than 3
unique tags (reads) per unique gene identified in the
HBRR and UHRR samples. In fact, when we mapped tags
to all possible enzymatic digestion sites, there were up to
50 unique tags per gene. For example, the analysis of 3
libraries (L1-L3) of HBRR indicates that the number of
unique tags per gene range from 1-46 tags with a mean of
4 and a median of 3 (data not shown). Figure 2 shows fre-
quency distribution plots of tags per digestion site (refer-
enced relative to the transcript 3' end), as a function of the
total number of reads analyzed. From the pool of more
than 200 million reads collected from the 35 HBRR flow
cell lanes, we randomly selected 5, 10, 15, or 20 million
reads for the incremental analysis. On average, in both
HBRR and UHRR samples, the 3' most DpnII digestion site
(position 1) accounts for 70-80% of the total mapped
tags, with an exponential decrease in the number of tags
observed as the digestion site becomes closer to the 5' end
region. However, there were multiple instances where the
tag count distribution for an individual transcript did not
fit this profile. This is the case for gene PGK1 (Additional
File 3, figure S3) where the two most abundant tags were
the 1st and 4th tags from the 3' end, each corresponding to
a known poly-adenylation site. This un-common profile
is therefore more likely due to the presence of multiple
poly-adenylation sites, although we couldn't exclude that
there might be concurrent incomplete digestion by DpnII.
We also briefly discussed other genes whose most abun-
dant tags were not the 3' most tags in Additional File 3, fig-
ure S4.
Transcriptome coverage vs. sequencing depth
In order to estimate the sequencing depth needed for suf-
ficient transcriptome coverage, we studied the cumulative
benefit of sequencing an increasing number of reads. Dif-
ferent sequencing depths were simulated by randomly
selecting 0.5, 1, 1.5, 2, 3, 5, 10, 15, 20, 30, 40, or all 96
million tags from the HBRR libraries. The number of
unique tags, the number of unique genes, and the
observed dynamic range were calculated at each sequenc-
ing depth (Figure 3). All three parameters increase as the
total number of tags sequenced increases. However, the
observation of novel tag sequences increased at substan-
tially faster rate then the observation of novel genes (Fig-
ure 3a), as less abundant gene tag types started to be
detected with the increase in sequencing depth.
Figure 3b plots the tag counts of the highest expressed
gene obtained from the 3' tag DGE at different sequencing
depths, which increase linearly as more sequences are
included in the analysis. Since the total number of genes
sequenced increases with higher sequencing depth, plot-
ting the tag counts of the highest expressed gene at any
given sequencing depth effectively plots the dynamic
range of the experiment. Although detection of very abun-
dant transcripts is not a challenge for any of the available
technologies, accurate quantification of such mRNAs is
another matter. All hybridization-based technologies are
susceptible to saturation, which limits the ability to com-
pare the level of expression of transcripts that are
expressed at very high levels in certain samples. Sequence
based quantification methods are theoretically not satura-
ble and should therefore exhibit a higher limit to the
dynamic range. According to literature, the highest
hybridization signals of an Affymetrix GeneChip array is
around 50,000 intensity units (15-16 log 2), without scal-
ing. The actual upper limit of the dynamic range of micro-
arrays is probably somewhat narrower if one considers
Distribution of tag frequency per DpnII digestion site (ordered 3' to 5') for samples UHRR (2a) and HBRR (2b) Figure 2
Distribution of tag frequency per DpnII digestion site (ordered 3' to 5') for samples UHRR (2a) and HBRR (2b).
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optical background from the scanner and non-specific
hybridizations, as well as the signal saturation. However,
if one accepts the assertion that the upper limit of the
dynamic range of microarrays is between 15 and 16 at
Log2 scale, then the limit is comparable to that of one lane
of 3' tag DGE using the older version GA I platform, which
generates 3-5 million tags per lane (Figure 3b). The newer
GA II platform generates 6-8 million tags per lane (as seen
with our data from the GA II instrument), and the most
recent iteration of the GA IIx is predicted to generate ~15-
20 million tags per lane (using Illumina Pipeline Software
version 1.4, Figure 3b). Increasing the total number of
sequences analyzed increases the upper limit of the
dynamic range of the DGE method, and Figure 3c clearly
illustrates that the distribution of the higher expressed
genes is not skewed, nor do the signals appear to reach a
saturation point as additional sequences are accumulated.
We conclude, therefore, that DGE technology has greater
power for quantification of high abundance transcripts,
compared to microarray technology.
3' DGE to quantitative real-time PCR (qPCR) comparisons
To assess the accuracy of 3' tag DGE, gene expression lev-
els were benchmarked against MAQC sample TaqMan
qPCR data [19]. There were 815 Ensembl genes in the
UHRR data set and 800 Ensembl genes in the HBRR data
set where expression results were available from both the
3' tag DGE and qPCR analyses. Pearson correlations of -
0.740 (p-value < 2.2 e-16) and -0.746 (p-value < 2.2 e-16)
and Spearman correlations of -0.765 (p-value < 2.2 e-16)
and -0.747 (p-value < 2.2 e-16) were obtained between
DGE and qPCR for UHRR and HBRR expression results,
respectively (Figure 4a and 4b). The negative correlation
reflects the fact that qPCR data is measured in amplifica-
tion cycles, with larger values associated to lower expres-
sion. The correlation in absolute expression levels was
skewed by a small number of outliers most of which were
low-expressed genes (lower right corner of Figures 4a and
4b). The discrepancy in expression quantitation for these
outliers genes may reflect limitations in the measurement
range for both technologies. Since measurement scales
Relationship in HBRR between increasing number of raw sequences analyzed (0.5 to 96 million) and the number of unique 3a - - tags and genes identified, 3b -- the increase in dynamic range of gene expression measurement, and 3c -- the impact on the  distribution of gene expression Figure 3
Relationship in HBRR between increasing number of raw sequences analyzed (0.5 to 96 million) and the 
number of unique 3a -- tags and genes identified, 3b -- the increase in dynamic range of gene expression meas-
urement, and 3c -- the impact on the distribution of gene expression.
(a)
(b)
Microarray dynamic range
Current GA II dynamic range
(b)
(c)BMC Genomics 2009, 10:531 http://www.biomedcentral.com/1471-2164/10/531
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differ between technologies, the differential expression
between UHRR and HBRR samples was also compared.
The Pearson and Spearman correlations between fold
change values for DGE and qPCR are -0.902 (p-value <
2.2e-16) and -0.876 (p-value < 2.2e-16) respectively, as is
illustrated in Figure 4c. According to the MAQC publica-
tion [17] the correlation of fold changes between Affyme-
trix microarray and qPCR is 0.92 which is slightly higher.
The high correlation of differential expression measured
by NGS and gold-standard qPCR validates and demon-
strates value in using NGS DGE for gene expression quan-
titation.
NGS vs. Affymetrix U133Plus 2.0 microarray in gene 
detection
A comparison between DGE and Affymetrix U133 Plus
2.0 microarray was performed since microarray technol-
ogy has been the primary method for measuring genome-
wide gene expression levels. Additional File 4 summarizes
the observed ENSEMBL gene expression in the Affymetrix
and NGS data. There were 17,303 UHRR and 17,187
HBRR unique ENSEMBL genes identified by the two tech-
nologies combined. Sixty-three percent of these genes
were commonly observed, 33% were only observed by 3'
tag DGE without a minimum count threshold, and 4%
were only observed by Affymetrix microarray. When
applying a >5-count threshold in the UHRR data set, the
total number of observed genes decreased by ~13% (Fig-
ure 5e); the percent of total genes detected by DGE and
microarray, by DGE alone, and by microarray alone is
respectively 70%, 24%, and 6%. Smoothed histogram
plots shown in Figure 5a-d provide additional informa-
tion regarding the expression characteristics of the genes
uniquely identified by each technology. UHRR or HBRR
genes identified by both technologies have normal distri-
butions centered on log2 5.3 CPMT DGE counts or log2 8.3
Affymetrix expression level. Genes identified by DGE (>0
or >5 counts) but not by Affymetrix microarray are pre-
dominantly low in abundance, with the total distribution
of expression represented by a decaying function peaking
at genes with a single count and running out to a few
genes with log216 counts. Conversely, the genes identified
by Affymetrix microarray but not by NGS were more uni-
formly distributed and did not exhibit preference towards
a specific expression level. The ability for DGE to quantify
higher numbers of low-expressed genes than the Affyme-
trix microarray was evident in both HBRR an UHRR sam-
ples.
The reproducibility of gene expression levels between
DGE and Affymetrix microarray was also evaluated. Addi-
tional File 3 figure S5 contains scatter plots of DGE expres-
sion versus Affymetrix expression for 10,980 ENSEMBL
genes in the UHRR sample, 10,856 in the HBRR sample,
and the UHRR-HBRR differential expression of 9512
genes. The Pearson correlations for the UHRR, HBRR, and
UHRR-HBRR differential expression, were respectively
0.668, 0.657, and 0.895. These correlations reflect the
observed agreement in expression levels determined by
the two technologies. However, a subset of genes with
low-expression determined by DGE has a wide range of
expression levels measured by Affymetrix microarray.
These genes may be reflective of cross-hybridization or
incorrect annotation in the microarray data, or genes that
Scatter plot of gene expression level measurements using the 3' tag DGE and qPCR technologies, for (4a) UHRR sample, (4b)  HBRR sample, and (4c) UHRR vs. HBRR differential expression Figure 4
Scatter plot of gene expression level measurements using the 3' tag DGE and qPCR technologies, for (4a) 
UHRR sample, (4b) HBRR sample, and (4c) UHRR vs. HBRR differential expression. The gene expression levels 
from qPCR are represented by PCR cycle number, and the expression levels from DGE are represented by Log2 of CPMT 
(counts per million tags)
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were poorly sequenced and incorrectly measured using
DGE.
Discussion and conclusion
Massively parallel sequencing for transcriptome profiling
generates digital counts of gene expression levels com-
pared to the "analog" hybridization signals from the tra-
ditional microarray or quantitative PCR methods. Our
analysis highlights the precise nature of DGE profiling, as
demonstrated by the high reproducibility between techni-
cal replicates of the same library run in different lanes, and
between biological replicates of different libraries on the
same or different flow cells runs. The correlations between
technical replicates were >0.97. Although variability
between biological replicates of two different libraries (L6
and L8) was less than 0.95, it is likely that the variance
came from library construction and not the sequencing
process, since the correlations between biological repli-
cates of the libraries constructed at one lab (Florida) were
excellent (> 0.95, Additional File 2). We also demon-
strated that DGE profiling is accurate. The measurement
of fold changes of genes between HBRR and UHRR was
highly correlated with data obtained from qPCR. This cor-
relation is similar to that between microarrays and qPCR.
With 20 million tags each from HBRR and UHRR library,
which is the current sequencing throughput of one lane of
sequencing on GA II, DGE detected 10-20% more tran-
scripts than microarrays, a majority of which were
expressed at levels below the sensitivity threshold of
microarray platforms. The detection of the lower-
expressed genes and the wider dynamic range have been
shown to be the main advantages by DGE compared to
microarray analysis, since other parameters evaluated
between the two platform were mostly comparable. It has
been suggested that lower expressed transcripts may
account for nearly half of all transcripts in a cell, and play
critical but currently undefined roles in pathology and
ENSEMBL gene expression distribution separated by method of detection and sample analyzed: expression distribution in DGE  counts for genes identified in (a) UHRR and (c) HBRR, by both DGE and Affymetrix microarray (red line), as well as by DGE  alone (blue line); expression distribution in Affymetrix microarray expression values for genes identified in (b) UHRR and (d)  HBRR, by both DGE and Affymetrix microarray (red line), as well as by Affymetrix alone (green line) Figure 5
ENSEMBL gene expression distribution separated by method of detection and sample analyzed: expression 
distribution in DGE counts for genes identified in (a) UHRR and (c) HBRR, by both DGE and Affymetrix micro-
array (red line), as well as by DGE alone (blue line); expression distribution in Affymetrix microarray expres-
sion values for genes identified in (b) UHRR and (d) HBRR, by both DGE and Affymetrix microarray (red line), 
as well as by Affymetrix alone (green line). The differential expression between UHRR and HBRR for genes identified by: 
(e) both DGE and Affymetrix, as well as, NGS alone, in NGS counts; (f) both NGS and Affymetrix, as well as, Affymetrix only, 
in Affymetrix microarray expression values. (g) Comparison of the number of expressed genes detected by DGE and microar-
rays. Values for relaxed (at least one read) and stringent (at least five reads) DGE parameters are in bold or in brackets, 
respectively.
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physiology. DGE's ability to quantify these transcripts
may open new horizons for the application of genomic
profiling to translational research. In addition, DGE may
lead to the discovery of new functional genomic regions.
For example, 13-15% of the reads from our DGE libraries
aligned to intergenic regions which may be related to
novel transcripts. However, since no DNase treatment was
performed during RNA extraction, these un-mapped reads
could also be from the contamination of the genomic
DNA although this scenario is less likely because of the
selection of PolyA+ RNAs during library construction.
One limitation of 3' DGE is that using a particular enzyme
such as DpnII for library preparation requires the presence
of DpnII restriction site(s) in the mRNA. Some transcripts,
even though highly expressed, may lack the DpnII site(s)
and therefore not represented in the libraries. Among all
43,569 transcripts in Human RefSeq RNA database (ver-
sion of Aug 24, 2009), 2,912 (6.68%) don't have a DpnII
site. Among 28,061 mature RNAs with accession numbers
starting with NM_ (excluding XR_, NR_ and XM_ acces-
sion numbers), 571 (2.04%) don't have a DpnII site. Addi-
tional File 5 lists all Human RefSeq RNAs and the number
of DpnII sites within each molecule. In addition, the non-
polyadenylated transcripts are not represented in the cur-
rent libraries. In an effort to measure both mRNA and
non-polyadenylated RNAs (data not shown), we tried to
treat total RNAs with RiboMinus™ Transcriptome Isola-
tion Kit (Invitrogen) prior to library preparation to
deplete 18S and 28S rRNAs and to enrich polyadenylated
mRNA, non-polyadenylated RNA, pre-processed RNA,
tRNA, and small rRNAs (5S rRNA, 5.8S rRNA). However,
the sequencing of RiboMinus libraries revealed that ~70%
of the reads were rRNAs (data not shown). Therefore, we
made a decision to prepare polyadenylated mRNA librar-
ies for the current study to avoid wasting sequencing
depth on rRNAs.
On the other hand, some of the genes that were detected
by Affymetrix only may only have DpnII tags that were
mapped to multiple genes. These tags were excluded from
our analysis. We point the readers to the web site of the
Stowers Institute where these redundantly mapped tags
were recorded http://research.stowers-institute.org/micro
array/tag_tables/downloads.html.
Several challenges currently limit the adoption of 3' DGE
in replacement of microarrays. The higher cost per sample
and low sample throughput per run limit the sample size
in a study. Currently 3' tag DGE analysis costs ~$1200 per
lane of sequencing including library construction. It also
has long individual run times, sequencing only ~12 bases
per day, and sample preparation is significantly more dif-
ficult and time consuming than that of microarray.
Finally, the bioinformatics challenges associated with
3'DGE analysis are significant, including storage, archiv-
ing, and retrieval of the vast volume of data, and develop-
ment of algorithms to assemble and align sequence reads
as short as 35-40 nucleotides [19]. However, advances in
these new sequencing technologies will substantially
increase sample throughput, leveraging techniques such
as multiplexing that could reduce the cost of sequencing
per sample. Bioinformatics challenges are currently being
addressed, faster and more powerful alignment tools
being developed.
We are aware that RNA-Seq enables a more extensive pro-
filing of the transcriptome by facilitating the discovery of
fusion genes [20], detection and quantification of alterna-
tive splice forms, and characterization of expressed muta-
tions and polymorphisms [14]. However, in order to
comprehensively sequence the full length of all tran-
scripts, the sequencing depth of RNA-seq needs to be sig-
nificantly greater compared to that of 3' tag DGE profiling.
It was estimated that at least 40 million reads (compared
to < 5 million reads required for DGE) needs to be
sequenced from a single library to achieve 90% coverage
of the transcriptome [10] making RNA-seq even more
financially demanding that 3' tag DGE. In addition, the
increased complexity of the data poses even greater ana-
lytic challenges. Therefore, the advantages of 3' tag DGE
over microarray in profiling lower-expressed genes and
measuring with greater dynamic range make it arguably
attractive for use in today's medical and biological
research.
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